Why has the gross mortality of dialysis patients increased in Japan?  by Akiba, Takashi et al.
Kidney International, Vol. 57, Suppl. 74 (2000), pp. S-60–S-65
MORTALITY
Why has the gross mortality of dialysis patients increased
in Japan?
TAKASHI AKIBA, SHIGERU NAKAI, TORU SHINZATO, CHIKAO YAMAZAKI, TATEKI KITAOKA,
KAZUO KUBO, and KENJI MAEDA
Patient Survey Committee, Japanese Society for Dialysis Therapy, Nagoya, Japan
Why has the gross mortality of dialysis patients increased in ments came from continuous efforts to increase dialysis
Japan? doses in hemodialysis and peritoneal dialysis patients,
Background. The gross mortality of Japanese chronic dial- as well as from implementation of a comprehensive ap-ysis patients gradually increased from 8.1% in 1983 to 9.4%
proach to prevent multi-systemic complications in dial-in 1997. We describe the demographic changes in dialysis pa-
ysis patients. In contrast, gross mortality of Japanesetients and clarify why the gross mortality has increased.
Methods. Data used in our analysis were taken from annual chronic dialysis therapy has been reportedly increasing.
reports by the Patient Registration Committee of the Japanese Our goals in this paper are to describe the demographic
Society for Dialysis Therapy. The relative risk of death was changes in dialysis patients and to clarify problems incalculated by a logistic regression procedure and Cox propor-
improving chronic dialysis therapy.tional hazard model.
Results. The first-year survival starting from the initiation
of dialysis therapy slowly improved from 0.836 in 1983 to 0.857
METHODSin 1996, but 5-year and 10-year survival consistently decreased
in the same patient groups. The patients’ mean age of beginning Data used in this analysis were taken from the annual
dialysis steadily increased from 51.9 in 1983 to 62.2 in 1997.
reports by the Patient Registration Committee of theThe incidence of patients with diabetes as the original disease
Japanese Society for Dialysis Therapy [4–9]. The Patientshowed a tremendous increase from 15.6% in 1983 to 33.9% in
1997, and patients with nephrosclerosis also showed a twofold Registration Committee’s patient survey method has
increase in our population. Heart failure accounted for 30–35% been described elsewhere [5–7]. Briefly, at the end of
of mortality until 1991, but this started to decrease after 1992, November from 1968 onward, the committee mailed the
when recombinant human erythropoietin became clinically
questionnaire form to the head doctors of all facilitiesavailable, and the level fell to 23.9% by 1997. The relative risk
listed in the society. The recipients were asked to returnof death in the first year of initiating dialysis therapy decreased
to almost half of the reference year 1983 (P , 0.0001). the survey replies by the end of the following March.
Conclusion. The increase in the gross mortality of Japanese The items surveyed were facility characteristics and de-
dialysis patients might not be due to a deteriorating quality of mographics. A longitudinal survey of first-time dialysisdialysis therapy, but rather is a reflection of accepting patients
patients and subsequent follow-up of their clinical andwith older age and comorbid factors contributing to higher
laboratory data was started in 1983. In 1994, we askedrisks of mortality with dialysis therapy.
facilities to respond using a Lotus 1-2-3 or Microsoft
Excel worksheet. This collection form was used by 986
facilities in 1998, making it possible to increase itemsIn 1984, we described huge differences in the mortality
surveyed to include factors such as doses of erythropoie-of dialysis patients in the United States, Europe, and
Japan [1]. Life expectancy of dialysis patients age 45–64 tin, cardiothoracic ratio, and predialysis systolic and dia-
years in the United States was almost one-third of that stolic blood pressure. Response rates in 1997 were 99.7%
for Japanese dialysis patients. Recent publications on for the items concerning facility status and 96.4% for
the mortality of dialysis patients in the United States the patient longitudinal surveys. As of the end of 1997,
have consistently reported significant improvements in 340,462 patients’ records had been registered in the pa-
gross mortality of hemodialysis and peritoneal dialysis tient longitudinal survey. Data analysis was executed
patients [2, 3]. These reports suggested that the improve- using SAS/STAT software (version 6.03, SAS Institute
Japan, Tokyo). The relative risk of death was calculated
by a logistic regression procedure and Cox proportionalKey words: survival, incidences, dialysis, aging, diabetic nephropathy,
ESRD hazard model as case-mix variables of gender, age, dura-
tion on dialysis, and original diseases. Reports from the 2000 by the International Society of Nephrology
S-60
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Fig. 2. Trends in survival of dialysis patients at first (j), fifth (r), and
tenth year (m), by year.
Fig. 1. Recent trends in the gross mortality (%/year) of dialysis patients
in Japan, 1983–1997.
Patient Registry Committee of the Japanese Society for
Dialysis Therapy were published annually [8]. The re-
ports were distributed to all members and participating
facilities at the annual meetings of the Japanese Society
for Dialysis Therapy. Excerpts from the reports were
published in the December issue of the Journal of the
Japanese Society for Dialysis Therapy each year [9].
RESULTS
The gross mortality rate of dialysis patients was 8.1%
in 1983, gradually increasing to 9.4% in 1997 (Fig. 1).
Survival of dialysis patients after the first year following
the initiation of dialysis therapy slowly improved from
0.836 in 1983 to 0.857 in 1997 (Fig. 2). In contrast, five-
year survival consistently decreased from 0.626 in pa-
tients who started dialysis in 1983 to 0.578 in patients who
started dialysis in 1992. Ten-year survival also showed
consistent declines.
The mean age of patients beginning dialysis was 51.9
in 1983, steadily increasing to 62.2 in 1997 (Fig. 3). The
mean age of patients receiving on-going dialysis treat-
ment also showed an increase, from 48.3 in 1983 to 59.2 in
1997. The average life span of the Japanese population,
expressed as a mean of males and females, was 76.99 in
1983 and gradually increased to 79.62 in 1994.
Fig. 3. Trends in the average life span of Japanese population (m),
Percent changes in the five main original diseases of the mean age of incident patients (r), and the mean age of the prevalent
patients (j), by year.patients initiating dialysis by the year in which dialysis
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Fig. 5. Trends in the distribution of main causes of death of dialysis
patients, 1983–1997. Recombinant erythropoietin became extensively
administered in 1992. Rare and unknown causes are not shown.Fig. 4. Distribution of five main original diseases of incident patients
by the year of the initiation of dialysis therapy.
therapy was begun are given in Fig. 4, which shows a
tremendous increase in diabetic patients from 15.6% in
1983 to 33.9% in 1997. Patients beginning dialysis who
had nephrosclerosis also increased twofold, from 3.0%
in 1983 to 6.8% in 1997. Patients starting dialysis who
had chronic glomerulonephritis concomitantly decreased
from 58.3% in 1983 to 36.6% in 1997, though the number
of new dialysis patients increased from 5,750 in 1983 to
10,703 in 1997.
The five main causes of death in dialysis patients were
heart failure, malignancy, infection, myocardial in-
farction, and cerebrovascular accident (Fig. 5). Heart
failure accounted for around 30–35% of mortality in
1991, but its incidence started to decrease from 1992,
when recombinant human erythropoietin (rHuEPO) be-
came extensively administered, and the level fell to
23.9% by 1997.
Twelve month survival of long-term dialysis patients
differed significantly by hematocrit (Hct) levels at the
end of 1994 (P , 0.0001) (Fig. 6). Survival rates at the
twelfth month were 0.761 for Hct ,15%, 0.853 for Hct
15–20%, 0.897 for Hct 20–25%, 0.939 for Hct 25–30%,
0.950 for Hct 30–35%, 0.943 for Hct 35–40%, and 0.945
for Hct .40%. Fig. 6. Survival of prevalent patients during 12 months of 1995 by
hematocrit (Hct) levels at the end of 1994.Relative risk of death after 1 year on dialysis was
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Fig. 7. Relative risk of 1-year death adjusted
by gender, age, duration on dialysis, and origi-
nal diseases. (A) original diseases (r, non-
diabetic; m, diabetes; j, total), (B) age at initi-
ation of dialysis therapy (j, 30-44 years; r,
45-59 years; m, 60–74 years).
adjusted by gender, age, duration on dialysis, and original coincided with the increase in the age of new dialysis
patients (Fig. 3), the increase in patients with diabeticdisease. Relative risk of death by the year when dialysis
therapy started decreased to almost half of that in the nephropathy as an original disease (Fig. 4), and the 7.7%
and 11.5% decreases of 5-year and 10-year survival, re-reference year 1983 (P , 0.0001) (Fig. 7A). Relative risk
spectively (Fig. 2).of death of diabetes patients decreased to 0.346, though
Better survival with higher hematocrit (Fig. 6) and thethat of non-diabetes patients moderately decreased to
percent reduction in deaths from congestive heart failure0.614.
coinciding with the introduction of the clinical use ofRelative risk of death was compared by the patient
rHuEPO (Fig. 5) might offset the degree of the increaseage at the initiation of dialysis therapy (Fig. 7B). There
in gross mortality to some extent. The relative risk of 1-did not appear to be any significant age-related differ-
year death in dialysis patients by the year when dialysisence in risk at the start of the therapy. Relative risk of
therapy was initiated showed significant and continuousdeath was 0.531 for patients aged 30–44 years, 0.528 for
improvements when that of 1983 was used as a referencepatients aged 45–59 years, and 0.429 for patients more
year (Fig. 7A). The improvement in the relative risk ofthan 60 years in 1995.
death was greater in diabetic patients than in non-dia-The changes in the addition of new patients and the
betic patients. In contrast, the risks of death in threedeath of dialysis patients in Japan were graphically com-
groups based on age at the initiation of dialysis therapypared (Fig. 8). The incidence of initiation of therapy and
showed recent improvement, although the degree of im-mortality rapidly increased from 1983 to 1997, and the
provement was not different among them (Fig. 7B).annual difference, which stood for the annual increase
The incidence of end-stage renal disease (ESRD) wasof long-term dialysis patients, continuously increased
suggested to show an exponential increase [2, 10]. Theover the same period. When the initiation incidence and
United States Renal Data System (USRDS) reportedthe number of deaths were plotted on a semilogarithmic
that incident patients in the United States doubled inscale, they both fitted to straight lines (r2 5 0.990 and
8.5 years [2]. Doubling occurred at a faster pace among0.993, respectively). The slope of the mortality was
patients with diabetes (6 years) and hypertension (7steeper than that of initiation incidence.
years) as causes of ESRD, as well as in elderly patients (6
years for age 75 to 84). Our observations in the Japanese
DISCUSSION population also showed that the aging process of the
population and demographic changes in original diseasesOur analysis of data from the Patient Registry over
the fifteen-year period from 1983 to 1997 disclosed that could be the main reasons for these exponential increases
in new dialysis patients [11].the death rate of dialysis patients showed a definite in-
crease from around 8% to 9.5% (Fig. 1). This increase The annual death rates of dialysis patients in the
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Fig. 8. Trends in incidence (j) and mortality
(r) of dialysis patients in Japan. (A) standard
scale; (B) semilogarithmic scale.
United States recently showed clear decreases, from 26% rather to the changes in aging, original diseases, or un-
in 1988 to 23% in 1995 [3]. Reports have suggested that measured factor(s). More aggressive approaches for the
these decreases in annual mortality might be attributed improvement of dialysis therapy might be needed to
to the increased delivery of dialysis dose, shift from cellu- overcome the high risk of patients to be treated in the
losic to synthetic hemodialysis membrane, and the use future.
of erythropoietin [3, 11]. The increases in gross mortality
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